Clinical Research and Clinical Trials of cancer
About Clinical Research and Clinical Trials of cancer
Clinical trials test whether new cancer treatments, tests and care approaches are safe and better than current options. Almost every advance in cancer care has come from patients and researchers taking part in clinical research.
The Clinical Research and Clinical Trials of cancer session at Cancer Research 2027 covers trial results, designs and methods. It connects closely with ethical considerations in cancer research and clinical trials, which sets the standards for safe and fair research.
Clinical trials move through phases, from testing safety in small groups to comparing treatments in large studies. Each phase answers different questions. Patients who join trials help improve care for everyone who follows. Well-run trials need careful design, ethics approval and strong teamwork.
Key Topics in Clinical Research and Clinical Trials of cancer
• Phase I to III cancer trials
• Adaptive, basket and umbrella trial designs
• Investigator-initiated trials
• Patient-reported outcomes
• Trial recruitment and diversity
• Decentralised and remote trials
• Real-world evidence in oncology
• Biomarker-driven trials
• Trials in radiotherapy and surgery
• Trial infrastructure in Asia-Pacific
Recent Advances in Clinical Research and Clinical Trials of cancer
Basket and umbrella trials test targeted drugs across many cancer types based on molecular changes, supporting precision oncology. Decentralised trials, with remote visits and home testing, are making it easier for patients to take part.
AI tools from role of artificial intelligence in oncology are helping find eligible patients faster. Asia-Pacific is becoming a major region for cancer trials, adding to advances in cancer research and treatment.
Trials are becoming more flexible, with designs that can adapt as results come in. More trials are measuring quality of life and patient-reported outcomes, not just survival. Efforts are under way to include more women, older people and diverse groups. Digital tools are also making it easier for patients to take part from home.
Who Should Attend the Clinical Research and Clinical Trials of cancer Session
• Clinical researchers and trial investigators
• Oncologists and research nurses
• Trial coordinators and data managers
• Biostatisticians
• PhD students and early-career researchers
• Pharma and contract research organisation staff
Why Present Your Research in Clinical Research and Clinical Trials of cancer
Presenting at Cancer Research 2027 puts your trial results in front of oncologists and researchers worldwide. You can share methods and connect with colleagues in cancer management and research working to bring trial results into routine care. Sharing trial results, including negative ones, helps avoid repeating work. Your methods and experience can also help other teams run better trials.
Frequently Asked Questions
Can I present a trial protocol or ongoing study?
Yes. Protocols and ongoing trials are welcome.
Are negative trial results accepted?
Yes. All well-conducted trials are welcome, whatever their results.
Where is Cancer Research 2027 held?
Cancer Research 2027 is held at Village Hotel Changi, Singapore, from 8 to 10 March 2027, with online participation.